Skip to main content

Table 2 Patients baseline

From: Autologous immuno magnetically selected CD133+ stem cells in the treatment of no-option critical limb ischemia: clinical and contrast enhanced ultrasound assessed results in eight patients

ID

Sex

Age

Risk factors

Diagnosis

Lesion’ site and extension

Rest pain

1

m

57

AH, hyperuricemia, HC, ESH

PAD

Left leg ulcer, 16 cm

+++

2

m

39

ESH

BD

Left foot ulcer, 2 cm

++

3

m

37

Hyperhomocysteinemia, ESH

BD

Left forefoot amputation dehiscence, 15 cm

+++

4

m

69

AH, ESH, HC

PAD

Right foot ulcer, 5 cm

++

5

f

41

ESH

BD

Right foot ulcer, 1 cm

++

6

m

34

ESH

BD

Left finger amputation dehiscence, 10 cm

+++

7

f

52

AS, AH, DM

PAD

None

+++

8

m

49

ESH

PAD

None

++

  1. AH arterial hypertension, HC hypercholesterolemia, ESH ex smoke habit, PAD peripheral arterial disease, BD buerger disease, AS active smoker, DM diabetes mellitus
  2. Pain scale: +mild, ++ moderate, +++ severe